A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC)
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2007
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 16 Nov 2007 Status changed from recruiting to completed.
- 06 Nov 2005 New trial record.